Use of a cannabinoid cb1 receptor antagonist for preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy
Номер патента: EP2037920A1
Опубликовано: 25-03-2009
Автор(ы): Fabio Guagnini, Roberta Avallone, Tiziano Croci
Принадлежит: Sanofi Aventis France
Опубликовано: 25-03-2009
Автор(ы): Fabio Guagnini, Roberta Avallone, Tiziano Croci
Принадлежит: Sanofi Aventis France
Реферат: The goal of the present invention is the use of a cannabinoid CB1 receptor antagonist for the preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy.
Use of antagonists and/or inverse agonists of cb1 receptors for preparing medicaments for treating fatigue post-viral fatigue syndrome
Номер патента: US20220152010A1. Автор: Antonio Oliviero,Vanesa Soto Leon,Manuel NIETO DÍAZ. Владелец: Fundacion Hospital Nacional De Parapejicos. Дата публикации: 2022-05-19.